Page last updated: 2024-08-16

probenecid and ceefourin 1

probenecid has been researched along with ceefourin 1 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abba, M; Attorresi, AI; Carozzo, A; Davio, C; Di Siervi, N; Diez, F; Fernández, N; Gómez, N; Monczor, F; Rodríguez-González, Á; Sahores, A; Shayo, C; Yaneff, A	1

Other Studies

1 other study(ies) available for probenecid and ceefourin 1

Article	Year
Identification of MRP4/ABCC4 as a Target for Reducing the Proliferation of Pancreatic Ductal Adenocarcinoma Cells by Modulating the cAMP Efflux. Molecular pharmacology, 2019, Volume: 96, Issue:1 Topics: Benzothiazoles; Carcinoma, Pancreatic Ductal; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cell Survival; Computer Simulation; Cyclic AMP; Gene Expression Regulation, Neoplastic; Gene Silencing; HEK293 Cells; Humans; Multidrug Resistance-Associated Proteins; Pancreatic Neoplasms; Probenecid; Prognosis; Propionates; Quinolines; Signal Transduction; Survival Analysis; Triazoles; Up-Regulation	2019

Article

Year

Identification of MRP4/ABCC4 as a Target for Reducing the Proliferation of Pancreatic Ductal Adenocarcinoma Cells by Modulating the cAMP Efflux.

Molecular pharmacology, 2019, Volume: 96, Issue:1

Topics: Benzothiazoles; Carcinoma, Pancreatic Ductal; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cell Survival; Computer Simulation; Cyclic AMP; Gene Expression Regulation, Neoplastic; Gene Silencing; HEK293 Cells; Humans; Multidrug Resistance-Associated Proteins; Pancreatic Neoplasms; Probenecid; Prognosis; Propionates; Quinolines; Signal Transduction; Survival Analysis; Triazoles; Up-Regulation

2019